You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cGVHD

Showing 1 - 25 of 350
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)

Approved for marketing
  • Graft-versus-host Disease (GVHD)
  • (no location specified)
Jan 26, 2023

cGVHD Trial in Guanzhou (Belimumab (Benlysta))

Withdrawn
  • cGVHD
  • Belimumab (Benlysta)
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Jan 16, 2023

Patients at Risk for Chronic Graft-Versus-Host Disease

Not yet recruiting
  • cGVHD
  • Non-Interventional
  • (no location specified)
Jun 16, 2023

GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)

Terminated
Has Results
  • Graft Versus Host Disease
  • +2 more
  • Ruxolitinib 1.5% cream
  • vehicle cream
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 21, 2022

Chronic GVHD Trial (Belumosudil)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • (no location specified)
Jan 5, 2023

Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Recruiting
  • Chronic Graft vs Host Disease
    • Bucheon-Si, Korea, Republic of
    • +9 more
    Jan 27, 2023

    Safety and Efficacy Trial in Suzhou (Chidamide)

    Recruiting
    • Safety and Efficacy
    • Suzhou, Jiangsu, China
      First Affiliated Hospital,Soochow University
    Nov 30, 2021

    Hematological Malignancies Trial in Durham (fostamatinib)

    Active, not recruiting
    • Hematological Malignancies
    • Durham, North Carolina
      Duke University of Medicine
    Jul 14, 2022

    Chronic GVHD Trial in Boston (Abatacept)

    Active, not recruiting
    • Chronic Graft Versus Host Disease
    • Boston, Massachusetts
    • +1 more
    Jan 25, 2022

    Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)

    Recruiting
    • Chronic Graft Versus Host Disease
    • Duarte, California
      City of Hope Site Number : 8400001
    Nov 23, 2023

    Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)

    Active, not recruiting
    • Chronic Graft vs Host Disease
    • Chronic Graft-Versus-Host Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 29, 2022

    GVHD, Chronic Trial in China (BN101)

    Recruiting
    • GVHD, Chronic
    • Beijing, China
    • +7 more
    Apr 24, 2022

    Chronic Graft-versus-host Disease (cGVHD) Trial in Aventura (AMG 592, Placebo)

    Completed
    • Chronic Graft-versus-host Disease (cGVHD)
    • AMG 592
    • Placebo
    • Aventura, Florida
      Research Site
    May 16, 2023

    Chronic Graft-versus-Host Disease (cGVHD) Trial in Randwick (AMG 592, Placebo)

    Completed
    • Chronic Graft-versus-Host Disease (cGVHD)
    • AMG 592
    • Placebo
    • Randwick, New South Wales, Australia
      Research Site
    May 23, 2023

    Chronic GVHD Trial in Duarte (biological, procedure, other)

    Active, not recruiting
    • Chronic Graft Versus Host Disease
    • Aldesleukin
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Dry Eye Trial in Guangzhou (Umbilical Mesenchymal Stem Cells derived Exosomes)

    Recruiting
    • Dry Eye
    • Umbilical Mesenchymal Stem Cells derived Exosomes
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Feb 10, 2022

    Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

    Recruiting
    • Chronic Graft vs Host Disease
    • Regulatory T-cell enriched infusion
    • Sevilla, Spain
      José Antonio Pérez Simón
    May 20, 2022

    Evaluation of Patients With Immune Function Abnormalities

    Recruiting
    • Chronic Granulomatous Disease (CGD)
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Pediatric cGVHD Symptom Scale

      Recruiting
      • Graft vs Host Disease
        • Aurora, Colorado
        • +11 more
        Jan 27, 2023

        aGVHD, cGVHD Trial in Beijing (Rabbit ATG)

        Recruiting
        • aGVHD
        • cGVHD
        • Rabbit ATG
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Feb 21, 2022

        Chronic Graft-versus-host-disease Trial in Shanghai (Anlotinib)

        Terminated
        • Chronic Graft-versus-host-disease
        • Shanghai, Shanghai, China
          Hematology Department
        Mar 22, 2021

        Specific Treatments in Patients With cGVHD, PQRST Study

        Recruiting
        • Chronic Graft Versus Host Disease
        • Biospecimen Collection
        • +3 more
        • Tampa, Florida
        • +7 more
        Aug 16, 2022

        GVHD Trial in Japan (Ibrutinib)

        Completed
        • Graft vs Host Disease
        • Anjo-shi, Japan
        • +14 more
        Dec 30, 2021

        Microbiota Composition With cGVHD After Allo-HSCT

        Recruiting
        • Hematopoietic Stem Cell Transplantation
        • +3 more
        • blood sample
        • stool sample
        • Hangzhou, Zhejiang, China
        • +9 more
        Jul 31, 2022

        Chronic Graft-versus-host-disease Trial in United States (Itacitinib)

        Recruiting
        • Chronic Graft-versus-host-disease
        • Denver, Colorado
        • +4 more
        Jan 24, 2022